{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:02:29Z","timestamp":1784800949700,"version":"3.55.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00284-026-05018-6","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:17:32Z","timestamp":1782285452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Viral Infections and Neurodegenerative Diseases: Reinterpreting the Crosstalk Through a Dual-Role Lens"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-5698","authenticated-orcid":false,"given":"Alireza","family":"Tahmtan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeranoot","family":"Nissapatorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmuga Sundar","family":"Saravanabhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0655-1060","authenticated-orcid":false,"given":"Soroush","family":"Taherkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9444-7337","authenticated-orcid":false,"given":"Bahman","family":"Aghcheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"1","key":"5018_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-025-02145-7","volume":"10","author":"Q Jiang","year":"2025","unstructured":"Jiang Q, Liu J, Huang S et al (2025) Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances. Signal Transduct Target Ther 10(1):76. https:\/\/doi.org\/10.1038\/s41392-025-02145-7","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5018_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12974-024-03139-y","volume":"21","author":"P Kettunen","year":"2024","unstructured":"Kettunen P, Koistinaho J, Rolova T (2024) Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review. J Neuroinflammation 21(1):152. https:\/\/doi.org\/10.1186\/s12974-024-03139-y","journal-title":"J Neuroinflammation"},{"issue":"12","key":"5018_CR3","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00702-023-02723-5","volume":"131","author":"J Sian-Hulsmann","year":"2024","unstructured":"Sian-Hulsmann J, Riederer P (2024) Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view. J Neural Transm (Vienna) 131(12):1429\u20131453. https:\/\/doi.org\/10.1007\/s00702-023-02723-5","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"5018_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41392-022-01118-4","volume":"7","author":"H Zhang","year":"2022","unstructured":"Zhang H, Shao L, Lin Z et al (2022) APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients. Signal Transduct Target Ther 7(1):261. https:\/\/doi.org\/10.1038\/s41392-022-01118-4","journal-title":"Signal Transduct Target Ther"},{"key":"5018_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.omtn.2023.07.031","volume":"33","author":"F Chen","year":"2023","unstructured":"Chen F, Ke Q, Wei W, Cui L, Wang Y (2023) Apolipoprotein E and viral infection: risks and mechanisms. Mol Ther Nucleic Acids 33:529\u2013542. https:\/\/doi.org\/10.1016\/j.omtn.2023.07.031","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"5018_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00415-025-13138-5","volume":"272","author":"PJ Oliver","year":"2025","unstructured":"Oliver PJ, Civitelli L, Hu MT (2025) The gut-brain axis in early Parkinson\u2019s disease: from prodrome to prevention. J Neurol 272(6):413. https:\/\/doi.org\/10.1007\/s00415-025-13138-5","journal-title":"J Neurol"},{"key":"5018_CR7","doi-asserted-by":"publisher","unstructured":"Ganz T, Ben-Hur T (2024) The hit and run hypothesis for Alzheimer\u2019s disease pathogenesis. Int J Mol Sci 25(6). https:\/\/doi.org\/10.3390\/ijms25063245","DOI":"10.3390\/ijms25063245"},{"issue":"1","key":"5018_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12967-024-06025-6","volume":"23","author":"S Shouman","year":"2025","unstructured":"Shouman S, Hesham N, Salem TZ (2025) Viruses and neurodegeneration: a growing concern. J Transl Med 23(1):46. https:\/\/doi.org\/10.1186\/s12967-024-06025-6","journal-title":"J Transl Med"},{"key":"5018_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102757","volume":"74","author":"X Ma","year":"2024","unstructured":"Ma X, Liao Z, Tan H et al (2024) The association between cytomegalovirus infection and neurodegenerative diseases: a prospective cohort using UK Biobank data. EClinicalMedicine 74:102757. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102757","journal-title":"EClinicalMedicine"},{"issue":"1","key":"5018_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40035-025-00507-3","volume":"14","author":"Y Lin","year":"2025","unstructured":"Lin Y, Yoo JM, Li Y et al (2025) Disease-disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes. Transl Neurodegener 14(1):52. https:\/\/doi.org\/10.1186\/s40035-025-00507-3","journal-title":"Transl Neurodegener"},{"issue":"2","key":"5018_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3003669","volume":"24","author":"KM Danzer","year":"2026","unstructured":"Danzer KM, Sparrer KM (2026) Could targeting viruses be a new hope against neurodegenerative diseases? PLoS Biol 24(2):e3003669. https:\/\/doi.org\/10.1371\/journal.pbio.3003669","journal-title":"PLoS Biol"},{"issue":"6","key":"5018_CR12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1021\/acschemneuro.4c00763","volume":"16","author":"K Bovis","year":"2025","unstructured":"Bovis K, Davies-Branch M, Day PJR (2025) Dysregulated neurotransmission and the role of viruses in Alzheimer\u2019s disease. ACS Chem Neurosci 16(6):982\u2013987. https:\/\/doi.org\/10.1021\/acschemneuro.4c00763","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"5018_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12915-019-0678-9","volume":"17","author":"SK Thaker","year":"2019","unstructured":"Thaker SK, Ch\u2019ng J, Christofk HR (2019) Viral hijacking of cellular metabolism. BMC Biol 17(1):59. https:\/\/doi.org\/10.1186\/s12915-019-0678-9","journal-title":"BMC Biol"},{"key":"5018_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.751516","volume":"8","author":"F Kong","year":"2021","unstructured":"Kong F, Li Q, Zhang F, Li X, You H, Pan X, Zheng K, Tang R (2021) Sirtuins as potential therapeutic targets for hepatitis B virus infection. Front Med (Lausanne) 8:751516. https:\/\/doi.org\/10.3389\/fmed.2021.751516","journal-title":"Front Med (Lausanne)"},{"key":"5018_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182921","author":"JK Kim","year":"2022","unstructured":"Kim JK, Silwal P, Jo EK (2022) Sirtuin 1 in host defense during infection. Cells. https:\/\/doi.org\/10.3390\/cells11182921","journal-title":"Cells"},{"issue":"1","key":"5018_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/21505594.2019.1605803","volume":"10","author":"P Mehrbod","year":"2019","unstructured":"Mehrbod P, Ande SR, Alizadeh J et al (2019) The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections. Virulence 10(1):376\u2013413. https:\/\/doi.org\/10.1080\/21505594.2019.1605803","journal-title":"Virulence"},{"key":"5018_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111497","volume":"125","author":"X Cheng","year":"2025","unstructured":"Cheng X, Zeng T, Xu Y, Xiong Y (2025) The emerging role of PANoptosis in viral infections disease. Cell Signal 125:111497. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111497","journal-title":"Cell Signal"},{"issue":"4","key":"5018_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167249","volume":"434","author":"LN Nguyen","year":"2022","unstructured":"Nguyen LN, Kanneganti TD (2022) PANoptosis in viral infection: the missing puzzle piece in the cell death field. J Mol Biol 434(4):167249. https:\/\/doi.org\/10.1016\/j.jmb.2021.167249","journal-title":"J Mol Biol"},{"key":"5018_CR19","doi-asserted-by":"publisher","first-page":"1550968","DOI":"10.3389\/fimmu.2025.1550968","volume":"16","author":"L Hong","year":"2025","unstructured":"Hong L, Chen X, Liu Y, Liang H, Zhao Y, Guo P (2025) The relationship between ferroptosis and respiratory infectious diseases: a novel landscape for therapeutic approach. Front Immunol 16:1550968. https:\/\/doi.org\/10.3389\/fimmu.2025.1550968","journal-title":"Front Immunol"},{"key":"5018_CR20","doi-asserted-by":"publisher","first-page":"1304281","DOI":"10.3389\/fimmu.2023.1304281","volume":"14","author":"OG Thomas","year":"2023","unstructured":"Thomas OG, Olsson T (2023) Mimicking the brain: Epstein-barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis. Front Immunol 14:1304281. https:\/\/doi.org\/10.3389\/fimmu.2023.1304281","journal-title":"Front Immunol"},{"key":"5018_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/v13060958","author":"K Speckhart","year":"2021","unstructured":"Speckhart K, Williams JM, Tsai B (2021) How DNA and RNA viruses exploit host chaperones to promote infection. Viruses. https:\/\/doi.org\/10.3390\/v13060958","journal-title":"Viruses"},{"issue":"4","key":"5018_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1055\/s-0043-1768698","volume":"81","author":"LC Fran\u00e7a","year":"2023","unstructured":"Fran\u00e7a LC, Fontes-Dantas FL, Garcia DG et al (2023) Molecular mimicry between Zika virus and central nervous system inflammatory demyelinating disorders: the role of NS5 Zika virus epitope and PLP autoantigens. Arq Neuropsiquiatr 81(4):357\u2013368. https:\/\/doi.org\/10.1055\/s-0043-1768698","journal-title":"Arq Neuropsiquiatr"},{"key":"5018_CR23","doi-asserted-by":"publisher","unstructured":"Maguire C, Wang C, Ramasamy A, et al (2024) Molecular mimicry as a mechanism of viral Immune evasion and autoimmunity. bioRxiv. https:\/\/doi.org\/10.1101\/2024.03.08.583134","DOI":"10.1101\/2024.03.08.583134"},{"key":"5018_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020327","author":"K Meng","year":"2025","unstructured":"Meng K, Jia H, Hou X et al (2025) Mitochondrial dysfunction in neurodegenerative diseases: mechanisms and corresponding therapeutic strategies. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13020327","journal-title":"Biomedicines"},{"key":"5018_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106907","volume":"209","author":"K Hou","year":"2025","unstructured":"Hou K, Pan W, Liu L et al (2025) Molecular mechanism of PANoptosis and programmed cell death in neurological diseases. Neurobiol Dis 209:106907. https:\/\/doi.org\/10.1016\/j.nbd.2025.106907","journal-title":"Neurobiol Dis"},{"key":"5018_CR26","doi-asserted-by":"publisher","unstructured":"Tsoi PS, Quan MD, Ferreon JC, Ferreon ACM (2023) Aggregation of disordered proteins associated with neurodegeneration. Int J Mol Sci 24(4). https:\/\/doi.org\/10.3390\/ijms24043380","DOI":"10.3390\/ijms24043380"},{"key":"5018_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02949","volume":"9","author":"M Saleh","year":"2018","unstructured":"Saleh M, R\u00fcschenbaum S, Welsch C et al (2018) Glycogen synthase kinase 3\u03b2 enhances hepatitis C virus replication by supporting miR-122. Front Microbiol 9:2949. https:\/\/doi.org\/10.3389\/fmicb.2018.02949","journal-title":"Front Microbiol"},{"key":"5018_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040820","author":"L Hoffmeister","year":"2020","unstructured":"Hoffmeister L, Diekmann M, Brand K, Huber R (2020) GSK3: a kinase balancing promotion and resolution of inflammation. Cells. https:\/\/doi.org\/10.3390\/cells9040820","journal-title":"Cells"},{"issue":"5","key":"5018_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.70006","volume":"35","author":"EC Ijezie","year":"2025","unstructured":"Ijezie EC, Miller MJ, Hardy C et al (2025) Herpes simplex virus-1 infection alters microtubule-associated protein tau splicing and promotes tau pathology in neural models of Alzheimer\u2019s disease. Brain Pathol 35(5):e70006. https:\/\/doi.org\/10.1111\/bpa.70006","journal-title":"Brain Pathol"},{"issue":"10","key":"5018_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010018","volume":"17","author":"SJ Park","year":"2021","unstructured":"Park SJ, Jin U, Park SM (2021) Interaction between coxsackievirus B3 infection and \u03b1-synuclein in models of Parkinson\u2019s disease. PLoS Pathog 17(10):e1010018. https:\/\/doi.org\/10.1371\/journal.ppat.1010018","journal-title":"PLoS Pathog"},{"key":"5018_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040514","author":"A Rocchi","year":"2025","unstructured":"Rocchi A, Wollebo HS, Khalili K (2025) Neurotropic viruses as acute and insidious drivers of aging. Biomolecules. https:\/\/doi.org\/10.3390\/biom15040514","journal-title":"Biomolecules"},{"issue":"1","key":"5018_CR32","doi-asserted-by":"publisher","first-page":"2514232","DOI":"10.1080\/27694127.2025.2514232","volume":"4","author":"AG Rader","year":"2025","unstructured":"Rader AG, Cloherty APM, Patel KS et al (2025) Autophagy-enhancing strategies to promote intestinal viral resistance and mucosal barrier function in SARS-CoV-2 infection. Autophagy Rep 4(1):2514232. https:\/\/doi.org\/10.1080\/27694127.2025.2514232","journal-title":"Autophagy Rep"},{"key":"5018_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11122902","author":"EG Gutman","year":"2023","unstructured":"Gutman EG, Fernandes RA, Raposo-Vedovi JV et al (2023) Molecular mimicry between SARS-CoV-2 proteins and human self-antigens related with autoimmune central nervous system (CNS) disorders. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms11122902","journal-title":"Microorganisms"},{"key":"5018_CR34","doi-asserted-by":"publisher","first-page":"1289170","DOI":"10.3389\/fcimb.2023.1289170","volume":"13","author":"H Zhai","year":"2023","unstructured":"Zhai H, Wang T, Liu D, Pan L, Sun Y, Qiu HJ (2023) Autophagy as a dual-faced host response to viral infections. Front Cell Infect Microbiol 13:1289170. https:\/\/doi.org\/10.3389\/fcimb.2023.1289170","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"5018_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29690","volume":"96","author":"JL Heinz","year":"2024","unstructured":"Heinz JL, Hinke DM, Maimaitili M et al (2024) Varicella zoster virus-induced autophagy in human neuronal and hematopoietic cells exerts antiviral activity. J Med Virol 96(6):e29690. https:\/\/doi.org\/10.1002\/jmv.29690","journal-title":"J Med Virol"},{"issue":"5","key":"5018_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41579-023-00995-y","volume":"22","author":"A Jassey","year":"2024","unstructured":"Jassey A, Jackson WT (2024) Viruses and autophagy: bend, but don\u2019t break. Nat Rev Microbiol 22(5):309\u2013321. https:\/\/doi.org\/10.1038\/s41579-023-00995-y","journal-title":"Nat Rev Microbiol"},{"key":"5018_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells14060418","author":"F Aligolighasemabadi","year":"2025","unstructured":"Aligolighasemabadi F, Bakinowska E, Kie\u0142bowski K et al (2025) Autophagy and respiratory viruses: mechanisms, viral exploitation, and therapeutic insights. Cells. https:\/\/doi.org\/10.3390\/cells14060418","journal-title":"Cells"},{"key":"5018_CR38","doi-asserted-by":"publisher","first-page":"1108212","DOI":"10.3389\/fnins.2023.1108212","volume":"17","author":"B Rocamonde","year":"2023","unstructured":"Rocamonde B, Hasan U, Mathieu C, Dutartre H (2023) Viral-induced neuroinflammation: different mechanisms converging to similar exacerbated glial responses. Front Neurosci 17:1108212. https:\/\/doi.org\/10.3389\/fnins.2023.1108212","journal-title":"Front Neurosci"},{"issue":"1","key":"5018_CR39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-021-02282-0","volume":"18","author":"S Hayley","year":"2021","unstructured":"Hayley S, Sun H (2021) Neuroimmune multi-hit perspective of coronaviral infection. J Neuroinflammation 18(1):231. https:\/\/doi.org\/10.1186\/s12974-021-02282-0","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5018_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12035-025-05409-z","volume":"63","author":"JM Lawrence","year":"2025","unstructured":"Lawrence JM, Dampier W, Mell JC et al (2025) Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat. Mol Neurobiol 63(1):251. https:\/\/doi.org\/10.1007\/s12035-025-05409-z","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5018_CR41","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41593-025-01871-z","volume":"28","author":"R Fekete","year":"2025","unstructured":"Fekete R, Simats A, B\u00edr\u00f3 E, P\u00f3sfai B et al (2025) Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19. Nat Neurosci 28(3):558\u2013576. https:\/\/doi.org\/10.1038\/s41593-025-01871-z","journal-title":"Nat Neurosci"},{"issue":"11","key":"5018_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2425670122","volume":"122","author":"N Orr","year":"2025","unstructured":"Orr N, Steinman L (2025) Epstein-Barr virus and the immune microenvironment in multiple sclerosis: insights from high-dimensional brain tissue imaging. Proc Natl Acad Sci U S A 122(11):e2425670122. https:\/\/doi.org\/10.1073\/pnas.2425670122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5018_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.907804","volume":"13","author":"VTA Tran","year":"2022","unstructured":"Tran VTA, Lee LP, Cho H (2022) Neuroinflammation in neurodegeneration via microbial infections. Front Immunol 13:907804. https:\/\/doi.org\/10.3389\/fimmu.2022.907804","journal-title":"Front Immunol"},{"key":"5018_CR44","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3389\/fmicb.2020.01992","volume":"11","author":"Z Ren","year":"2020","unstructured":"Ren Z, Zhang X, Ding T et al (2020) Mitochondrial dynamics imbalance: a strategy for promoting viral infection. Front Microbiol 11:1992. https:\/\/doi.org\/10.3389\/fmicb.2020.01992","journal-title":"Front Microbiol"},{"issue":"4","key":"5018_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2565","volume":"34","author":"T Jiang","year":"2024","unstructured":"Jiang T, Zhu K, Kang G, Wu G, Wang L, Tan Y (2024) Infectious viruses and neurodegenerative diseases: the mitochondrial defect hypothesis. Rev Med Virol 34(4):e2565. https:\/\/doi.org\/10.1002\/rmv.2565","journal-title":"Rev Med Virol"},{"issue":"1","key":"5018_CR46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X (2025) Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther 10(1):190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5018_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s44298-024-00057-x","volume":"2","author":"R Boytz","year":"2024","unstructured":"Boytz R, Keita K, Pawlak JB, Laurent-Rolle M (2024) Flaviviruses manipulate mitochondrial processes to evade the innate immune response. Npj Viruses 2(1):47. https:\/\/doi.org\/10.1038\/s44298-024-00057-x","journal-title":"Npj Viruses"},{"key":"5018_CR48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuropharm.2017.02.008","volume":"117","author":"Y Wang","year":"2017","unstructured":"Wang Y, Santerre M, Tempera I, Martin K, Mukerjee R, Sawaya BE (2017) HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging. Neuropharmacology 117:364\u2013375. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.008","journal-title":"Neuropharmacology"},{"key":"5018_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179206","author":"Z Sun","year":"2024","unstructured":"Sun Z, Wang Y, Jin X, Li S, Qiu HJ (2024) Crosstalk between dysfunctional mitochondria and proinflammatory responses during viral infections. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25179206","journal-title":"Int J Mol Sci"},{"key":"5018_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051955","author":"X Duan","year":"2025","unstructured":"Duan X, Liu R, Lan W, Liu S (2025) The essential role of mitochondrial dynamics in viral infections. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26051955","journal-title":"Int J Mol Sci"},{"key":"5018_CR51","doi-asserted-by":"publisher","first-page":"1603125","DOI":"10.3389\/fneur.2025.1603125","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Mu S, Liu F (2025) Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications. Front Neurol 16:1603125. https:\/\/doi.org\/10.3389\/fneur.2025.1603125","journal-title":"Front Neurol"},{"key":"5018_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115363","volume":"211","author":"D Ye","year":"2024","unstructured":"Ye D, Chukwu C, Yang Y, Hu Z, Chen H (2024) Adeno-associated virus vector delivery to the brain: technology advancements and clinical applications. Adv Drug Deliv Rev 211:115363. https:\/\/doi.org\/10.1016\/j.addr.2024.115363","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"5018_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70091","volume":"6","author":"B Qie","year":"2020","unstructured":"Qie B, Tuo J, Chen F, Ding H (2020) Lyu L (2025) Gene therapy for genetic diseases: challenges and future directions. MedComm 6(2):e70091. https:\/\/doi.org\/10.1002\/mco2.70091","journal-title":"MedComm"},{"issue":"4","key":"5018_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","volume":"22","author":"G Ferrari","year":"2021","unstructured":"Ferrari G, Thrasher AJ, Aiuti A (2021) Gene therapy using haematopoietic stem and progenitor cells. Nat Rev Genet 22(4):216\u2013234. https:\/\/doi.org\/10.1038\/s41576-020-00298-5","journal-title":"Nat Rev Genet"},{"issue":"17","key":"5018_CR55","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1016\/j.cell.2023.07.031","volume":"186","author":"AL Epstein","year":"2023","unstructured":"Epstein AL, Haag-Molkenteller C (2023) Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB). Cell 186(17):3523\u20133523-e3521. https:\/\/doi.org\/10.1016\/j.cell.2023.07.031","journal-title":"Cell"},{"issue":"6701","key":"5018_CR56","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.adm8386","volume":"384","author":"Q Huang","year":"2024","unstructured":"Huang Q, Chan KY, Wu J et al (2024) An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery. Science 384(6701):1220\u20131227. https:\/\/doi.org\/10.1126\/science.adm8386","journal-title":"Science"},{"key":"5018_CR57","doi-asserted-by":"publisher","first-page":"1750807","DOI":"10.3389\/fmolb.2025.1750807","volume":"12","author":"X Xu","year":"2025","unstructured":"Xu X (2025) Strategies of AAV capsid engineering for targeted delivery to brain, muscle, and retina. Front Mol Biosci 12:1750807. https:\/\/doi.org\/10.3389\/fmolb.2025.1750807","journal-title":"Front Mol Biosci"},{"issue":"1","key":"5018_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10238-025-01691-2","volume":"25","author":"S Rivera-Orellana","year":"2025","unstructured":"Rivera-Orellana S, Bautista J, Palacios-Zavala D et al (2025) Oncolytic virotherapy and tumor microenvironment modulation. Clin Exp Med 25(1):256. https:\/\/doi.org\/10.1007\/s10238-025-01691-2","journal-title":"Clin Exp Med"},{"issue":"8","key":"5018_CR59","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.ymthe.2025.04.046","volume":"33","author":"TC Moyer","year":"2025","unstructured":"Moyer TC, Hoffman BA, Chen W et al (2025) Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier. Mol Ther 33(8):3902\u20133916. https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.046","journal-title":"Mol Ther"},{"issue":"1","key":"5018_CR60","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1038\/s41467-024-52149-0","volume":"15","author":"TF Shay","year":"2024","unstructured":"Shay TF, Jang S, Brittain TJ et al (2024) Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder. Nat Commun 15(1):7853. https:\/\/doi.org\/10.1038\/s41467-024-52149-0","journal-title":"Nat Commun"},{"key":"5018_CR61","unstructured":"Study Details. AB-1005 Long-Term Follow-Up Study. ClinicalTrials.gov. Available online: https:\/\/clinicaltrials.gov\/study\/NCT07081841?term=AB-1005&rank=2. Accessed 8 Mar 2026"},{"key":"5018_CR62","unstructured":"Study Details. A study to investigate the efficacy and safety of bemdaneprocel in adults who have Parkinson\u2019s disease. ClinicalTrials.gov. Available online: Accessed 8 Mar 2026 https:\/\/clinicaltrials.gov\/study\/NCT06944522"},{"issue":"1","key":"5018_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12951-025-03895-w","volume":"24","author":"M Jiang","year":"2025","unstructured":"Jiang M, Zhang K, Wang Z et al (2025) Nanomaterials in gene therapy and genome editing: challenges and emerging directions. J Nanobiotechnology 24(1):56. https:\/\/doi.org\/10.1186\/s12951-025-03895-w","journal-title":"J Nanobiotechnology"},{"key":"5018_CR64","unstructured":"Study Details. Safety and Proof-of-Concept (POC) Study with AMT-130 in Adults with Early Manifest Huntington\u2019s Disease. ClinicalTrials.gov. Available online: https:\/\/clinicaltrials.gov\/study\/NCT04120493?term=AMT-130&rank=2. Accessed 8 Mar 2026"},{"key":"5018_CR65","unstructured":"Study Details. Safety and Efficacy of AMT-130 in European Adults with Early Manifest Huntington\u2019s Disease. ClinicalTrials.gov. Available online: https:\/\/clinicaltrials.gov\/study\/NCT05243017?term=AMT-130&rank=1 Accessed 8 Mar 2026"},{"key":"5018_CR66","unstructured":"Study Details. A Randomized Study of SPK-10001 Gene Therapy in Participants with Huntington\u2019s Disease. ClinicalTrials. gov. Available online: https:\/\/clinicaltrials.gov\/study\/NCT06826612?cond=huntington%20disease&intr=AAV&rank=3 Accessed 17 Mar 2026"},{"key":"5018_CR67","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0495-18.2019","author":"KE Savell","year":"2019","unstructured":"Savell KE, Bach SV, Zipperly ME et al (2019) A neuron-optimized CRISPR\/dCas9 activation system for robust and specific gene regulation. eNeuro. https:\/\/doi.org\/10.1523\/eneuro.0495-18.2019","journal-title":"eNeuro"},{"issue":"16","key":"5018_CR68","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1016\/j.cell.2025.06.038","volume":"188","author":"AA Sousa","year":"2025","unstructured":"Sousa AA, Terrey M, Sakai HA et al (2025) In vivo prime editing rescues alternating hemiplegia of childhood in mice. Cell 188(16):4275\u20134294-e4223. https:\/\/doi.org\/10.1016\/j.cell.2025.06.038","journal-title":"Cell"},{"key":"5018_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cells15080720","author":"A Elias","year":"2026","unstructured":"Elias A, Stern S (2026) Gene editing strategies for neurological and mental disorders: advances in delivery, methodology, and clinical translation. Cells. https:\/\/doi.org\/10.3390\/cells15080720","journal-title":"Cells"},{"issue":"3","key":"5018_CR70","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cell.2025.12.039","volume":"189","author":"J Lin","year":"2026","unstructured":"Lin J, Lin Y, Liu N et al (2026) AAVLINK: A potent DNA-recombination method for large cargo delivery in gene therapy. Cell 189(3):969\u2013986-e917. https:\/\/doi.org\/10.1016\/j.cell.2025.12.039","journal-title":"Cell"},{"issue":"1","key":"5018_CR71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43856-023-00419-1","volume":"4","author":"MC Lauffer","year":"2024","unstructured":"Lauffer MC, van Roon-Mom W, Aartsma-Rus A (2024) Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders. Commun Med (Lond) 4(1):6. https:\/\/doi.org\/10.1038\/s43856-023-00419-1","journal-title":"Commun Med (Lond)"},{"issue":"1","key":"5018_CR72","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y (2023) The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther 8(1):217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"5018_CR73","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.apsb.2025.10.016","volume":"16","author":"Y Chen","year":"2026","unstructured":"Chen Y, Sun X, Xi Y et al (2026) Pathology-directed drug delivery strategies: How to overcome blood-brain barrier for the treatment of brain diseases. Acta Pharm Sin B 16(4):2250\u20132281. https:\/\/doi.org\/10.1016\/j.apsb.2025.10.016","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"5018_CR74","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41590-022-01208-z","volume":"23","author":"L Yshii","year":"2022","unstructured":"Yshii L, Pasciuto E, Bielefeld P et al (2022) Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation. Nat Immunol 23(6):878\u2013891. https:\/\/doi.org\/10.1038\/s41590-022-01208-z","journal-title":"Nat Immunol"},{"issue":"1","key":"5018_CR75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10571-026-01703-z","volume":"46","author":"HE Marei","year":"2026","unstructured":"Marei HE (2026) Recent advances in the non-viral delivery of genes to central nervous system disorders. Cell Mol Neurobiol 46(1):78. https:\/\/doi.org\/10.1007\/s10571-026-01703-z","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"5018_CR76","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","volume":"22","author":"Q Ling","year":"2023","unstructured":"Ling Q, Herstine JA, Bradbury A, Gray SJ (2023) AAV-based in vivo gene therapy for neurological disorders. Nat Rev Drug Discov 22(10):789\u2013806. https:\/\/doi.org\/10.1038\/s41573-023-00766-7","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"5018_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s44386-025-00037-y","volume":"3","author":"A Singh","year":"2026","unstructured":"Singh A, Tekade M, Nagaraja S, Bharti A, Tekade RK (2026) Advancements in RNA-based therapies from bench to bedside. npj Drug Discov 3(1):4. https:\/\/doi.org\/10.1038\/s44386-025-00037-y","journal-title":"npj Drug Discov"},{"issue":"1","key":"5018_CR78","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00253-025-13620-0","volume":"109","author":"Z Wang","year":"2025","unstructured":"Wang Z, Peng Y, Zhou H, Zhang M, Ju D, Chen Z (2025) MiRNA-based drugs: challenges and delivery strategies. Appl Microbiol Biotechnol 109(1):247. https:\/\/doi.org\/10.1007\/s00253-025-13620-0","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"5018_CR79","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12985-024-02286-1","volume":"21","author":"M Hadi","year":"2024","unstructured":"Hadi M, Qutaiba BAO, Jabari M (2024) Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma. Virol J 21(1):17. https:\/\/doi.org\/10.1186\/s12985-024-02286-1","journal-title":"Virol J"},{"issue":"2","key":"5018_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032112","volume":"10","author":"DP Devanand","year":"2020","unstructured":"Devanand DP, Andrews H, Kreisl WC et al (2020) Antiviral therapy: valacyclovir treatment of alzheimer\u2019s disease (VALAD) trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial. BMJ Open 10(2):e032112. https:\/\/doi.org\/10.1136\/bmjopen-2019-032112","journal-title":"BMJ Open"},{"issue":"7","key":"5018_CR81","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40263-025-01187-3","volume":"39","author":"BAC Cree","year":"2025","unstructured":"Cree BAC, Berger JR, Greenberg B (2025) Correction: the evolution of anti-CD20 treatment for multiple sclerosis: optimization of antibody characteristics and function. CNS Drugs 39(7):721\u2013724. https:\/\/doi.org\/10.1007\/s40263-025-01187-3","journal-title":"CNS Drugs"},{"issue":"1","key":"5018_CR82","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12951-025-03433-8","volume":"23","author":"M Wang","year":"2025","unstructured":"Wang M, Liu H, Huang J, Cai T, Xu ZP, Zhang L (2025) Advancing cancer gene therapy: the emerging role of nanoparticle delivery systems. J Nanobiotechnology 23(1):362. https:\/\/doi.org\/10.1186\/s12951-025-03433-8","journal-title":"J Nanobiotechnology"},{"key":"5018_CR83","doi-asserted-by":"publisher","unstructured":"Zhao R, Wang C, Li J, et al (2026) DNA and RNA editing for the therapy of human diseases: current status, challenges, and future prospects. Mol Biomed 7(1). https:\/\/doi.org\/10.1186\/s43556-026-00456-x","DOI":"10.1186\/s43556-026-00456-x"},{"issue":"1","key":"5018_CR84","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13023-025-03893-z","volume":"20","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Peng H, Ma Y, Yuan H, Jiang H (2025) In vivo applications and toxicities of AAV-based gene therapies in rare diseases. Orphanet J Rare Dis 20(1):368. https:\/\/doi.org\/10.1186\/s13023-025-03893-z","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"5018_CR85","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11910-024-01338-x","volume":"24","author":"KH Narsinh","year":"2024","unstructured":"Narsinh KH, Perez E, Haddad AF et al (2024) Strategies to improve drug delivery across the blood- brain barrier for glioblastoma. Curr Neurol Neurosci Rep 24(5):123\u2013139. https:\/\/doi.org\/10.1007\/s11910-024-01338-x","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"5018_CR86","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41398-025-03639-2","volume":"15","author":"R-Y Liu","year":"2025","unstructured":"Liu R-Y, Yin K-F, He S-Y et al (2025) Viral infections and the risk of neurodegenerative diseases: a comprehensive meta-analysis and systematic review. Transl Psychiatry 15(1):388. https:\/\/doi.org\/10.1038\/s41398-025-03639-2","journal-title":"Transl Psychiatry"},{"key":"5018_CR87","doi-asserted-by":"publisher","unstructured":"Weller B, Lin CW, Rothballer S, Calderwood MA, Falter-Braun P, Falter C (2026) NeuroViOme: a viral orfeome collection for studies of neurodegenerative disease. J Neurovirol 32(2). https:\/\/doi.org\/10.1007\/s13365-025-01303-5","DOI":"10.1007\/s13365-025-01303-5"},{"issue":"11","key":"5018_CR88","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00705-021-05223-7","volume":"166","author":"M Rastegar","year":"2021","unstructured":"Rastegar M, Samadizadeh S, Yasaghi M et al (2021) Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking. Arch Virol 166(11):3117\u20133126. https:\/\/doi.org\/10.1007\/s00705-021-05223-7","journal-title":"Arch Virol"},{"key":"5018_CR89","doi-asserted-by":"publisher","first-page":"8823863","DOI":"10.1155\/2023\/8823863","volume":"2023","author":"E Norasi","year":"2023","unstructured":"Norasi E, Rastegar M, Hosseini SD, Aghcheli B, Tahamtan A (2023) Prevalence of CCR5 Delta 32 genetic variant in the Turkmen population of Golestan province. northeast Iran Biomed Res Int 2023:8823863. https:\/\/doi.org\/10.1155\/2023\/8823863","journal-title":"Northeast Iran Biomed Res Int"},{"key":"5018_CR90","doi-asserted-by":"publisher","DOI":"10.1177\/1721727x221125436","author":"B Aghcheli","year":"2022","unstructured":"Aghcheli B, Behboudi E, Tabarraei A et al (2022) Serum cytokine\/chemokine profile and clinical\/paraclinical data in COVID-19 deceased and recovered patients. Eur J Inflamm. https:\/\/doi.org\/10.1177\/1721727x221125436","journal-title":"Eur J Inflamm"},{"key":"5018_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint17120197","author":"JM Dong","year":"2025","unstructured":"Dong JM, Zhong H (2025) Systematic review: proteomics-driven multi-omics integration for Alzheimer\u2019s disease pathology and precision medicine. Neurol Int. https:\/\/doi.org\/10.3390\/neurolint17120197","journal-title":"Neurol Int"},{"issue":"1","key":"5018_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s44337-026-00578-9","volume":"3","author":"SK Niazi","year":"2026","unstructured":"Niazi SK (2026) RNA interference therapeutics for disease-associated proteins: from molecular design to clinical translation. Discov Med 3(1):19. https:\/\/doi.org\/10.1007\/s44337-026-00578-9","journal-title":"Discov Med"},{"issue":"4","key":"5018_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00434","volume":"21","author":"RV Patel","year":"2024","unstructured":"Patel RV, Nanda P, Richardson RM (2024) Neurosurgical gene therapy for central nervous system diseases. Neurotherapeutics 21(4):e00434","journal-title":"Neurotherapeutics"},{"key":"5018_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/v17020239","author":"L Zwi-Dantsis","year":"2025","unstructured":"Zwi-Dantsis L, Mohamed S, Massaro G, Moeendarbary E (2025) Adeno-associated virus vectors: principles, practices, and prospects in gene therapy. Viruses. https:\/\/doi.org\/10.3390\/v17020239","journal-title":"Viruses"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05018-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:14:57Z","timestamp":1784798097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-05018-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":94,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5018"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-05018-6","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":3,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"451"}}